Home / Tag Archives: Rhofade

News: Rhofade


Rhofade (oxymetazoline hydrochloride) FDA Approval

Rhofade

Company: Allergan Approval Status: Approved January 2017 Specific Treatments: facial erythema associated with rosacea Therapeutic Areas Dermatology General Information Rhofade (oxymetazoline hydrochloride) is an alpha1A adrenoceptor agonist. Oxymetazoline acts as a vasoconstrictor. Rhofade is spccifically indicated for the topical treatment of persistent facial erythema associated with rosacea in adults. Rhofade is supplied as a cream for …

Read More »